---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-023545"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2022-01-31T23:59:59+00:00"
generated_at: "2026-06-27T13:26:10.716026+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vaccinex raises $9.7M in private placement of 8.75M shares at $1.11; January equity total $13.2M

## Summary
- Private placement closed Jan 31 with 8,747,744 shares at $1.11/share; gross proceeds ~$9.7M after amendment adding 2.8M shares.
- Affiliated investors include CEO Maurice Zauderer ($2M), Chairman Albert Friedberg ($2M), and director Jacob Frieberg.
- Additional $3.5M raised via ATM sales earlier in January at weighted avg $1.16/share, bringing month total to ~$13.2M.
- Proceeds will fund development of lead drug candidate pepinemab in cancer and neurodegenerative disease.
- Registration rights agreement requires filing resale shelf within 75 days; failure triggers liquidated damages.

## SEC filing metadata
- accession: 0001193125-22-023545
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2022-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312522023545/0001193125-22-023545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312522023545/d285729d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-023545
- JSON: https://secwatch.observer/filing/0001193125-22-023545.json
- Plain text: https://secwatch.observer/filing/0001193125-22-023545.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.